Funding for Medical Research
and Clinical Trials
and Clinical Trials
Funding Details for Alzheimers/Dementia/Aging
Use the contact information shown for the organization to apply for the funding.
Please notify CenTrial of any offer is incorrect or has expired.
Please notify CenTrial of any offer is incorrect or has expired.
Aging and Geriatrics
American Federation for Aging Research (AFAR)
Type of Organization: Foundation
Email Address: grants@afar.org
Funds Available for Clinical Trials: ✔ Research: ✔
Must be a full-time faculty member at the rank of Assistant Professor or higher at the time of the LOI deadline. To be competitive at the Assistant Professor level, a candidate would be expected to have established R01 or equivalent funding. The Glenn Foundation Discovery Award does not substitute for the R01 funding mechanism, but supports new, rather than incremental, research projects in established laboratories.
Must have a strong record of independent publication beyond the postdoctoral level
Cannot be a Principal Investigator supported through the Paul F. Glenn Centers for Biology of Aging Research.
Must conduct the proposed research at qualified not-for-profit setting in the United States.
Investigators who may not have previously worked in the area of aging, but whose research interests and expertise are relevant and could lead to discoveries in understanding the biology of normal aging are strongly encouraged to apply.
Former AFAR Research Grant for Junior Faculty awardees may apply; former Glenn Foundation Breakthrough In Gerontology (BIG) awardees may NOT apply. If you are applying for a 2024 Glenn Foundation for Medical Research and AFAR Grant for Junior Faculty, you may NOT also apply for the 2024 GFMR Discovery Award.
Questions about eligibility and suitability of research project can be addressed to grants@afar.org.
Selection Criteria
Applications are reviewed based on the following criteria:
Potential of the proposed research to (i) yield new discoveries in biology applicable to human aging and healthspan, or (ii) establish new approaches for clinically relevant strategies, treatments, and therapeutics that address human aging and health span.
Qualifications and research record of the applicant.
Excellence of the research environment.
Other info: The Glenn Foundation for Medical Research (GFMR) in collaboration with the American Federation for Aging Research (AFAR), has established the Glenn Foundation Discovery Award. This Award was created to support research projects with strong potential to develop pioneering discoveries for understanding the underlying biological mechanisms that govern normal human aging and its related physiological decline. Relevant proposals from any branch of biology are eligible. This funding program specifically seeks to include principal investigators who may not have previously worked in the area of aging, but whose research and expertise are applicable to understanding the biological mechanisms of normal aging and its relevance to age-associated health decline.
Projects that characterize aging as a disease, or that focus on specific diseases are discouraged unless the research plan provides direct connections to the biology of aging and/or the prospect of a translational discovery relevant to improving human healthspan.
Applications Open Early Next Year.
American Federation for Aging Research (AFAR)
Type of Organization: Foundation
Email Address: grants@afar.org
Funds Available for Clinical Trials: ✔ Research: ✔
Funding Details
Requirements: To be eligible, the applicant :Must be a full-time faculty member at the rank of Assistant Professor or higher at the time of the LOI deadline. To be competitive at the Assistant Professor level, a candidate would be expected to have established R01 or equivalent funding. The Glenn Foundation Discovery Award does not substitute for the R01 funding mechanism, but supports new, rather than incremental, research projects in established laboratories.
Must have a strong record of independent publication beyond the postdoctoral level
Cannot be a Principal Investigator supported through the Paul F. Glenn Centers for Biology of Aging Research.
Must conduct the proposed research at qualified not-for-profit setting in the United States.
Investigators who may not have previously worked in the area of aging, but whose research interests and expertise are relevant and could lead to discoveries in understanding the biology of normal aging are strongly encouraged to apply.
Former AFAR Research Grant for Junior Faculty awardees may apply; former Glenn Foundation Breakthrough In Gerontology (BIG) awardees may NOT apply. If you are applying for a 2024 Glenn Foundation for Medical Research and AFAR Grant for Junior Faculty, you may NOT also apply for the 2024 GFMR Discovery Award.
Questions about eligibility and suitability of research project can be addressed to grants@afar.org.
Selection Criteria
Applications are reviewed based on the following criteria:
Potential of the proposed research to (i) yield new discoveries in biology applicable to human aging and healthspan, or (ii) establish new approaches for clinically relevant strategies, treatments, and therapeutics that address human aging and health span.
Qualifications and research record of the applicant.
Excellence of the research environment.
Other info: The Glenn Foundation for Medical Research (GFMR) in collaboration with the American Federation for Aging Research (AFAR), has established the Glenn Foundation Discovery Award. This Award was created to support research projects with strong potential to develop pioneering discoveries for understanding the underlying biological mechanisms that govern normal human aging and its related physiological decline. Relevant proposals from any branch of biology are eligible. This funding program specifically seeks to include principal investigators who may not have previously worked in the area of aging, but whose research and expertise are applicable to understanding the biological mechanisms of normal aging and its relevance to age-associated health decline.
Projects that characterize aging as a disease, or that focus on specific diseases are discouraged unless the research plan provides direct connections to the biology of aging and/or the prospect of a translational discovery relevant to improving human healthspan.
Applications Open Early Next Year.